Socioeconomic measures influence survival in osteosarcoma: an analysis of the National Cancer Data Base

被引:45
作者
Miller, Benjamin J. [1 ]
Gao, Yubo [1 ]
Duchman, Kyle R. [1 ]
机构
[1] Univ Iowa Hosp & Clin, Dept Orthopaed & Rehabil, 200 Hawkins Dr,01008 JPP, Iowa City, IA 52242 USA
关键词
Osteosarcoma survival; overall survival; socioeconomic status; HIGH-GRADE OSTEOSARCOMA; SEER PROGRAM DATABASE; STUDY-GROUP PROTOCOLS; PROGNOSTIC-FACTORS; METASTATIC OSTEOSARCOMA; OSTEOGENIC-SARCOMA; EPIDEMIOLOGY; SURVEILLANCE; EXPERIENCE; CHEMOTHERAPY;
D O I
10.1016/j.canep.2017.05.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: While previous studies have identified low socioeconomic status as a risk factor for metastatic disease in patients with high-grade osteosarcoma, the influence of socioeconomic status on overall survival remains unclear. The present study aims to investigate the relationship between survival and socioeconomic status in patients with high-grade conventional osteosarcoma. Methods: The National Cancer Data Base (NCDB) was queried from 1998-2012 to identify all patients <40 years of age with a diagnosis of high-grade conventional osteosarcoma. A total of 3,503 patients were identified that met inclusion and exclusion criteria. Univariate relationships were investigated using Kaplan-Meier survival analysis and associated log-rank tests in order to determine patient, socioeconomic, tumor, and treatment variables associated with overall survival. Multivariate analysis was performed to determine independent predictors of survival. Results: In order of decreasing magnitude, metastatic disease (Hazard Ratio [HR] 3.28, 95% Confidence Interval [CI] 2.82-3.82), primary site in the pelvis or spine (HR 2.15, 95% CI 1.79-2.59), positive surgical margins (HR 1.82, 95% CI 1.46-2.27), tumor size >8 cm (HR 1.47, 95% CI 1.24-1.74), age >= 18 years (HR 1.30, 95% CI 1.14-1.48), lowest quartile of composite socioeconomic status (HR 1.23, 95% CI 1.02-1.51), and Medicaid insurance (HR 1.18, 95% CI 1.02-1.38) were predictors of decreased survival at 5 years. Conclusion: Treating providers should be aware that some of their patients may have challenges unrelated to their diagnosis that make timely presentation, adherence to treatment, and continued close surveillance difficult. This investigation suggests that socioeconomic variables influence overall survival for osteosarcoma in the United States, although not as dramatically as established tumor-and treatment-related risk factors. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:112 / 117
页数:6
相关论文
共 30 条
[1]  
American College of Surgeons, 2013, NCDB PART US FIL 201
[2]  
[Anonymous], NAT CANC DAT BAS
[3]   Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide [J].
Bacci, G ;
Briccoli, A ;
Rocca, M ;
Ferrari, S ;
Donati, D ;
Longhi, A ;
Bertoni, F ;
Bacchini, P ;
Giacomini, S ;
Forni, C ;
Manfrini, M ;
Galletti, S .
ANNALS OF ONCOLOGY, 2003, 14 (07) :1126-1134
[4]  
Berner K., 2015, PROGNOSTIC FACTORS T
[5]   Do Surgical Margins Affect Local Recurrence and Survival in Extremity, Nonmetastatic, High-grade Osteosarcoma? [J].
Bertrand, Todd E. ;
Cruz, Alex ;
Binitie, Odion ;
Cheong, David ;
Letson, G. Douglas .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2016, 474 (03) :677-683
[6]   Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols [J].
Bielack, SS ;
Kempf-Bielack, B ;
Delling, G ;
Exner, GU ;
Flege, S ;
Helmke, K ;
Kotz, R ;
Salzer-Kuntschik, M ;
Werner, M ;
Winkelmann, W ;
Zoubek, A ;
Jürgens, H ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :776-790
[7]   Tumor size and prognosis in aggressively treated osteosarcoma [J].
Bieling, P ;
Rehan, N ;
Winkler, P ;
Helmke, K ;
Maas, R ;
Fuchs, N ;
Bielack, S ;
Heise, U ;
Jurgens, H ;
Treuner, J ;
Romanowski, R ;
Exner, U ;
Kotz, R ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :848-858
[8]   The National Cancer Data Base: A powerful initiative to improve cancer care in the United States [J].
Bilimoria, Karl Y. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Ko, Clifford Y. .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (03) :683-690
[9]  
Carsi B, 2002, CLIN ORTHOP RELAT R, P53
[10]   A review of clinical and molecular prognostic factors in osteosarcoma [J].
Clark, Jonathan C. M. ;
Dass, Crispin R. ;
Choong, Peter F. M. .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (03) :281-297